# Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study

> **NCT04982471** · — · TERMINATED · sponsor: **Celgene** · enrollment: 36 (actual)

## Conditions studied

- Lymphoma, Non-Hodgkin
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Follicular

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04982471
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-03
- **Primary completion:** 2023-08-03
- **Final completion:** 2023-08-03
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04982471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04982471, "Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04982471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*